Some results have been hidden because they may be inaccessible to you.Show inaccessible results
HCPs: OPDIVO® (nivolumab) + | YERVOY® (ipilimumab) Combo
SponsoredVisit HCP Site To Determine If The Dual I-O Treatment O+Y Is Right For Your Patients. Review Efficacy & Safety Data For The Dual I-O Therapy OPDIVO® + YERVOY® (O+Y).For Healthcare Providers · FDA-Approved Treatment · Prescription Treatment
Types: HCP Resources, Efficacy Data, Important Safety Info, Dosing Schedules & GuideLearn Cancer Immunotherapy | Harvard Cancer Immunotherapy
SponsoredLearn About Cutting-Edge Cancer Immunotherapies from Harvard Medical School Faculty. Understand CAR T Cell Therapy, Checkpoint Blockade And More In This Unique Online Course.Earn a Certificate · Clinical Applications · Flexible Schedule · 100% Online